Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2020

Open Access 01-12-2020 | Insulins | Research article

Clinical profiles, outcomes and risk factors among type 2 diabetic inpatients with diabetic ketoacidosis and hyperglycemic hyperosmolar state: a hospital-based analysis over a 6-year period

Authors: Xiao-yan Wu, Dun-min She, Fang Wang, Gang Guo, Ran Li, Ping Fang, Ling Li, Yun Zhou, Ke-qin Zhang, Ying Xue

Published in: BMC Endocrine Disorders | Issue 1/2020

Login to get access

Abstract

Objective

Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are the two most common hyperglycemic emergencies (HEs) associated with diabetes mellitus. Individuals with HEs can present with combined features of DKA and HHS. The objective of this study is to assess the clinical characteristics, therapeutic outcomes, and associated predisposing factors of type 2 diabetic patients with isolated or combined HEs in China.

Methods

We performed a retrospective analysis of 158 patients with type 2 diabetes (T2DM), complicated with DKA, HHS, or DKA combined with HHS (DKA-HHS) in Shanghai Tongji Hospital, China from 2010 to 2015. Admission clinical features, therapeutic approaches and treatment outcomes of those patients were extracted and analyzed.

Results

Of the 158 patients with T2DM, 65 (41.1%) patients were DKA, 74 (46.8%) were HHS, and 19 (12.0%) were DKA-HHS. The most common precipitants were infections (111, 70.3%), newly diagnosed diabetes (28,17.7%) and non-compliance to medications (9, 5.7%). DKA patients were divided into mild, moderate and severe group, based on arterial blood gas. Spearman correlation analysis revealed that C-reaction protein (CRP) was positively correlated with severity of DKA, whereas age and fasting C peptide were inversely correlated with severity of DKA (P < 0.05). The mortality was 10.8% (17/158) in total and 21.6% (16/74) in the HHS group, 5.9% (1/17) in DKA-HHS. Spearman correlation analysis indicated that death in patients with HHS was positively correlated to effective plasma osmolality (EPO), renal function indicators and hepatic enzymes, while inversely associated with the continuous subcutaneous insulin infusion (CSII) therapy. Logistic regression analysis suggested that elevated blood urea nitrogen (BUN) on admission was an independent predisposing factor of mortality in HHS, while CSII might be a protective factor for patients with HHS. Furthermore, the receiver-operating characteristic (ROC) curve analysis indicated that BUN had the largest area under the ROC curves for predicting death in patients with HHS.

Conclusions

Our findings showed elevated CRP and decreased fasting C-peptide might serve as indicator for severe DKA. Elevated BUN might be an independent predictor of mortality in patients with HHS, whereas CSII might be a protective factor against death in HHS.
Literature
5.
go back to reference Miyake Y. Management of Hyperglycemic Crises and Severe Hypoglycemia in the Emergency Department. Brain Nerve. 2014;66(2):97–105.PubMed Miyake Y. Management of Hyperglycemic Crises and Severe Hypoglycemia in the Emergency Department. Brain Nerve. 2014;66(2):97–105.PubMed
9.
go back to reference Chu CH, Lee JK, Lam HC, Lu CC. Prognostic factors of hyperglycemic hyperosmolar nonketotic state. Chang Gung Med J. 2001;24(6):345–151.PubMed Chu CH, Lee JK, Lam HC, Lu CC. Prognostic factors of hyperglycemic hyperosmolar nonketotic state. Chang Gung Med J. 2001;24(6):345–151.PubMed
12.
go back to reference Pasquel FJ, Tsegka K, Wang H, Cardona S, Galindo RJ, Fayfman M, et al. Clinical outcomes in patients with isolated or combined diabetic ketoacidosis and hyperosmolar hyperglycemic state: a retrospective, hospital-based cohort study. Diabetes Care. 2020;43(2):349–57. https://doi.org/10.2337/dc19-1168.CrossRefPubMed Pasquel FJ, Tsegka K, Wang H, Cardona S, Galindo RJ, Fayfman M, et al. Clinical outcomes in patients with isolated or combined diabetic ketoacidosis and hyperosmolar hyperglycemic state: a retrospective, hospital-based cohort study. Diabetes Care. 2020;43(2):349–57. https://​doi.​org/​10.​2337/​dc19-1168.CrossRefPubMed
19.
go back to reference Graves EJ, Kozak LJ. Detailed Diagnoses and Procedures, National Hospital Discharge Survey, 1996. Vital Health Stat 13. 1998;i-iii(138):1–151. Graves EJ, Kozak LJ. Detailed Diagnoses and Procedures, National Hospital Discharge Survey, 1996. Vital Health Stat 13. 1998;i-iii(138):1–151.
30.
go back to reference Barski L, Nevzorov R, Rabaev E, Jotkowitz A, Harman-Boehm I, Zektser M, et al. Diabetic ketoacidosis: clinical characteristics, precipitating factors and outcomes of care. Isr Med Assoc J. 2012;14(5):299–303.PubMed Barski L, Nevzorov R, Rabaev E, Jotkowitz A, Harman-Boehm I, Zektser M, et al. Diabetic ketoacidosis: clinical characteristics, precipitating factors and outcomes of care. Isr Med Assoc J. 2012;14(5):299–303.PubMed
36.
go back to reference J Hans DeVries, Frank J Snoek, Piet J Kostense, Nathalie Masurel, Robert J Heine, Dutch Insulin Pump Study Group. A Randomized Trial of Continuous Subcutaneous Insulin Infusion and Intensive Injection Therapy in Type 1 Diabetes for Patients With Long-Standing Poor Glycemic Control. Diabetes Care. 2002 ;25(11):2074–2080. https://doi.org/10.2337/diacare.25.11.2074. J Hans DeVries, Frank J Snoek, Piet J Kostense, Nathalie Masurel, Robert J Heine, Dutch Insulin Pump Study Group. A Randomized Trial of Continuous Subcutaneous Insulin Infusion and Intensive Injection Therapy in Type 1 Diabetes for Patients With Long-Standing Poor Glycemic Control. Diabetes Care. 2002 ;25(11):2074–2080. https://​doi.​org/​10.​2337/​diacare.​25.​11.​2074.
Metadata
Title
Clinical profiles, outcomes and risk factors among type 2 diabetic inpatients with diabetic ketoacidosis and hyperglycemic hyperosmolar state: a hospital-based analysis over a 6-year period
Authors
Xiao-yan Wu
Dun-min She
Fang Wang
Gang Guo
Ran Li
Ping Fang
Ling Li
Yun Zhou
Ke-qin Zhang
Ying Xue
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2020
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-020-00659-5

Other articles of this Issue 1/2020

BMC Endocrine Disorders 1/2020 Go to the issue